321 related articles for article (PubMed ID: 32433508)
1. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.
Laurent AP; Kotecha RS; Malinge S
Leukemia; 2020 Aug; 34(8):1984-1999. PubMed ID: 32433508
[TBL] [Abstract][Full Text] [Related]
2. Trisomy of chromosome 21 in leukemogenesis.
Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
[TBL] [Abstract][Full Text] [Related]
3. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
4. Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia.
Kempski HM; Chessells JM; Reeves BR
Leukemia; 1997 Nov; 11(11):1973-7. PubMed ID: 9369434
[TBL] [Abstract][Full Text] [Related]
5. Unique clinical and biological features of leukemia in Down syndrome children.
Xavier AC; Ge Y; Taub J
Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
[TBL] [Abstract][Full Text] [Related]
6. Hematological disorders in children with Down syndrome.
Triarico S; Trombatore G; Capozza MA; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
[TBL] [Abstract][Full Text] [Related]
7. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome.
Wang N; Leung J; Warrier RP; Schorin M; Kirkpatrick D; Nowak MJ; Strand R
Cancer Genet Cytogenet; 1987 Sep; 28(1):155-62. PubMed ID: 2955885
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
9. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
[TBL] [Abstract][Full Text] [Related]
10. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.
Malinge S; Bliss-Moreau M; Kirsammer G; Diebold L; Chlon T; Gurbuxani S; Crispino JD
J Clin Invest; 2012 Mar; 122(3):948-62. PubMed ID: 22354171
[TBL] [Abstract][Full Text] [Related]
11. [Constitutional chromosome anomalies and acute leukemia].
Turc-Carel C; Mugneret F; Sidaner I
Sem Hop; 1983 Sep; 59(32):2267-72. PubMed ID: 6314516
[TBL] [Abstract][Full Text] [Related]
12. Equal frequency of TEL/AML1+ acute lymphoblastic leukemia in children with and without Down syndrome.
Steiner M; Attarbaschi A; König M; Gadner H; Haas OA; Mann G
Pediatr Hematol Oncol; 2005; 22(1):11-6. PubMed ID: 15770827
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic studies in children with Down syndrome and acute leukemia.
Valladares A; Palma-Padilla V; Mejía-Aranguré JM; Guevara-Yánez R; Lerma-Reyes A; Salamanca-Gómez F
Leuk Res; 2005 Nov; 29(11):1241-6. PubMed ID: 16164980
[TBL] [Abstract][Full Text] [Related]
14. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome and leukemia, an update.
Drabkin HA; Erickson P
Prog Clin Biol Res; 1995; 393():169-76. PubMed ID: 8545449
[TBL] [Abstract][Full Text] [Related]
16. The role of chromosome 21 in hematology and oncology.
Fonatsch C
Genes Chromosomes Cancer; 2010 Jun; 49(6):497-508. PubMed ID: 20232485
[TBL] [Abstract][Full Text] [Related]
17. Equal frequency of TEL/AML1 rearrangements in children with acute lymphoblastic leukemia with and without Down syndrome.
Steiner M; Attarbaschi A; König M; Nebral K; Gadner H; Haas OA; Mann G;
Pediatr Hematol Oncol; 2005; 22(3):229-34. PubMed ID: 16020107
[TBL] [Abstract][Full Text] [Related]
18. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.
Kubota Y; Uryu K; Ito T; Seki M; Kawai T; Isobe T; Kumagai T; Toki T; Yoshida K; Suzuki H; Kataoka K; Shiraishi Y; Chiba K; Tanaka H; Ohki K; Kiyokawa N; Kagawa J; Miyano S; Oka A; Hayashi Y; Ogawa S; Terui K; Sato A; Hata K; Ito E; Takita J
Cancer Sci; 2019 Oct; 110(10):3358-3367. PubMed ID: 31385395
[TBL] [Abstract][Full Text] [Related]
19. Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia.
Rogan PK; Close P; Blouin JL; Seip JR; Gannutz L; Ladda RL; Antonarakis SE
Am J Med Genet; 1995 Nov; 59(2):174-81. PubMed ID: 8588582
[TBL] [Abstract][Full Text] [Related]
20. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
Tigay JH
J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
